ABEO
Companies
NASDAQ
Abeona Therapeutics Inc.
Health Care
$6.01
+$0.44 (+7.90%)
Price Chart
Overview
About ABEO
Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel AIM.
Market Cap
$175.9M
Volume
10.6M
Avg. Volume
15.5M
P/E Ratio
-4.3378377
Dividend Yield
0.00%
Employees
91.0
Company Information
Risk & Correlation Analysis
Market Correlation
0.57
Low Correlation
Volatility
High (0.64)
Relative to market
Macro Factor Sensitivities
Interest Rates
Low Sensitivity
Inflation
Medium Sensitivity
GDP Growth
Medium Sensitivity
Liquidity
Low Sensitivity
Commodity Prices
Low Sensitivity
Credit Quality
Medium Sensitivity
Portfolio Impact
Forecasts & Predictions
1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential
Technical Analysis
Based on technical indicators and chart patterns, ABEO shows...
AI Sentiment Analysis
Market sentiment analysis indicates...
Key Statistics
Market Cap$175.9M
Volume10.6M
P/E Ratio-4.34
Dividend Yield0.00%
Important Dates
Next Dividend
Next Earnings
May 15, 2025Related Securities
Pricing info last updated June 17, 2025 (after market close)Other info last updated April 2, 2025